A Multicenter, Randomized, Double-blind Trial to Assess the Efficacy and Safety of ASC-01 in Patients With Major Depressive Disorder
Phase of Trial: Phase III
Latest Information Update: 20 Mar 2017
At a glance
- Drugs Aripiprazole/sertraline (Primary) ; Sertraline
- Indications Major depressive disorder
- Focus Registrational; Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 16 Mar 2017 Status changed from active, no longer recruiting to completed.
- 16 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 15 Nov 2016 Planned End Date changed from 1 Oct 2016 to 1 Mar 2017.